Non Salt Form
Medications like semaglutide belong to a family of drugs called GLP-1 receptor agonists. These medications work by slowing down digestion (delaying gastric emptying).
When the stomach takes more time to digest food, this sends powerful signals to your brain that you're full (even when you are eating less than normal).
People taking semaglutide lose weight because they eat less, and feel fuller after small meals.
Medications in the GLP-1 receptor agonist class function by slowing digestion, which includes delaying the emptying of the stomach.
(delaying gastric emptying).
When the stomach takes more time to digest food, this sends powerful signals to your brain that you're full (even when you are eating less than normal).
People taking GLP-1 lose weight because they eat less, and feel fuller after small meals.
GLP-1 is a receptor agonist. It works by regulating insulin and glucagon, leading to reduced appetite, delayed gastric emptying, and improved glucose control, all contributing to weight loss.
Your weight loss depends on many biologic factors including the duration and dosages that you receive. While individual results may vary, customers may potentially achieve weight loss targets of up to 30 pounds in the first three months of treatment, and possibly 50 pounds after 6 months.
GLP-1 comes in the form of a sterile liquid solution that is administered via subcutaneous injection once a week. It starts with a titrate to reduce side effects.
Dosages of GLP-1 for weight loss vary and are determined based on individual factors. Healthcare providers will prescribe an appropriate dosage, often titrated up gradually to achieve optimal results while minimizing potential side effects.
Given the theoretical risk, GLP-1 should be avoided in those with a personal or family history of medullary thyroid carcinoma.
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
All Rights Reserved | Primary Peak Medical Care